Gardasil™– Quadrivalent HPV Vaccine
Jacqeline van Schoor
Abstract
Jacqeline van Schoor
Abstract
Gardasil™is a new vaccine used to prevent cervical cancer and genital warts caused by human papillomavirus (HPV) types 6, 11, 16 and 18. The vaccine targets the HPV strains that are associated with 70% of cervical cancers (i.e. HPV 16 and 18) and with 90% of genital warts (i.e. HPV 6 and 11). While HPV 6 and 11 are not associated with cervical cancer, they can cause abnormal Pap smears.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Gardasil™is a new vaccine used to prevent cervical cancer and genital warts caused by human papillomavirus (HPV) types 6, 11, 16 and 18. The vaccine targets the HPV strains that are associated with 70% of cervical cancers (i.e. HPV 16 and 18) and with 90% of genital warts (i.e. HPV 6 and 11). While HPV 6 and 11 are not associated with cervical cancer, they can cause abnormal Pap smears.
Key concepts: Gardasil, Genital warts, Medicine, Cervical cancer, Sex organ, Human papillomavirus, HPV vaccines, Virology